Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 4 1Phase 3 1Phase 2/3 1

Status

Completed 45Unknown 8Terminated 8Recruiting 8Active not recruiting 8Withdrawn 1Not yet recruiting 1No longer available 1

Sponsor Class

OTHER 5INDUSTRY 2NETWORK 1

Study Type

Interventional 7Observational 1

Sponsor

Cancer Type

Lymphoid 8

Conditions

Hodgkin Disease 8Mycosis Fungoides 3Lymphoma, T-Cell, Peripheral 3Recurrence 2Lymphoma, T-Cell, Cutaneous 2Sezary Syndrome 1Mesothelioma, Malignant 1Lymphomatoid Papulosis 1Lymphoma, T-Cell 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Follicular 1Lymphoma 1Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1Leukemia, Large Granular Lymphocytic 1

Interventions

Cyclophosphamide 13pembrolizumab 8Brentuximab Vedotin 8fludarabine 7Nivolumab 7Whole-Body Irradiation 6Specimen Handling 6Mycophenolic Acid 6Gemcitabine 6Etoposide 6Doxorubicin 6Dacarbazine 6fludarabine phosphate 5Vinblastine 5Melphalan 5Granulocyte Colony-Stimulating Factor 5Filgrastim 5Dexamethasone 5Stem Cell Transplantation 4Cytarabine 4Vinorelbine 3Tacrolimus 3Magnetic Resonance Spectroscopy 3Cyclosporine 3Carmustine 3Blood Specimen Collection 3thymoglobulin 2polatuzumab vedotin 2pegylated granulocyte colony-stimulating factor 2pegfilgrastim 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

8 trials
RecentStart dateEnrollment
Recruiting × Hodgkin Disease × Brentuximab Vedotin × Clear all
NCT04685616 2026-06-02

RADAR

University College, London

Phase 3 Recruiting
1,042 enrolled
Lymphoid

Hodgkin Disease

NCT06377566 2026-04-23

A Study of BV-AVD in People With Bulky Hodgkin Lymphoma

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
71 enrolled
Lymphoid

Hodgkin Disease

NCT05481437 2026-04-13

A Survey of Brentuximab Vedotin in Pediatric Participants With Hodgkin Lymphoma

Takeda

Recruiting
8 enrolled
Lymphoid

Hodgkin Disease

NCT06831370 2026-02-23

A Study of Brentuximab Vedotin With Doxorubicin, Vinblastine and Dacarbazine in Adults With Hodgkin Lymphoma in India

Takeda

Phase 4 Recruiting
124 enrolled
Lymphoid

Hodgkin Disease, Lymphoma

NCT05180097 2026-02-02

Pembrolizumab and Brentuximab Vedotin vs GDP and Stem Cell Transplant for Relapsed/Refractory Hodgkin Lymphoma

Canadian Cancer Trials Group

Phase 2 Recruiting
84 enrolled
Lymphoid

Hodgkin Disease

NCT07002216 2025-11-03

BrECADD

University of Miami

Phase 2 Recruiting
48 enrolled
Lymphoid

Hodgkin Disease

NCT05595447 2025-03-12

Treatment Strategy for Relapsed/Refractory Hodgkin Lymphoma

Hospital Regional de Alta Especialidad del Bajio

Phase 2/3 Recruiting
20 enrolled
Lymphoid

Hodgkin Disease, Recurrence

NCT04378647 2024-02-26

BRESELIBET

Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea

Phase 2 Recruiting
150 enrolled
Lymphoid

Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡